Nuclear Power Is Having a Moment, and These 3 Stocks Are the Best to Buy Right Now

The article highlights three nuclear-related stocks positioned to benefit from AI- and cloud-driven demand for 24/7 power: Oklo, Nano Nuclear Energy, and NuScale Power. Oklo has early data center partnerships but still needs regulatory approval; Nano is advancing multiple microreactor concepts, including a space reactor; and NuScale has NRC-approved SMR designs but is still seeking commercial deployment. The piece is constructive on the sector, though it remains early-stage and high-risk.

Analysis

The market is starting to price nuclear less as a pure power-generation story and more as a pick-and-shovel play on AI infrastructure buildout. That matters because the first beneficiaries are likely not the eventual utility-scale winners, but the companies that can monetize developer relationships, permitting optionality, and “site power” scarcity before a reactor is ever operating. In that setup, OKLO has the cleanest commercial narrative because data-center partnerships can keep the equity bid alive through a long regulatory runway, while SMR has the most credible de-risked technology but the weakest near-term catalyst stack.

Second-order effects favor large data-center operators and infrastructure landlords more than the reactor names themselves. If on-site nuclear becomes a feasible long-duration power source, EQIX and META gain negotiating leverage on power procurement and uptime, but they also inherit execution risk if customers start demanding lower-carbon, always-on capacity without commensurate rent or lease economics. The bigger risk is that the current enthusiasm compresses future funding rounds for early-stage reactor developers: once the market assumes “nuclear optionality,” any regulatory delay, cost overrun, or site-development miss can trigger sharp multiple reset.

The contrarian read is that NNE is the least durable expression of the theme despite the broadest design surface area. Multiple concepts increase strategic optionality, but they also diffuse management focus and make commercialization harder to handicap; in markets, that often converts into higher story beta rather than higher terminal value. SMR may actually be the cleaner way to express a long-duration nuclear thesis if the goal is lower regulatory uncertainty, while OKLO remains the highest torque vehicle to AI power scarcity but with the most binary timing risk.

Catalyst-wise, the next 3-6 months matter more for sentiment than cash flow: any new customer MOU, site-selection announcement, or DOE/NRC milestone can re-rate the group again, but a single adverse permitting headline could unwind a large portion of the move. Over 12-24 months, the key variable is not reactor design quality but whether capital markets continue funding pre-revenue infrastructure stories at premium valuations.

Key Decisions for Investors

• Long OKLO vs short a basket of unprofitable clean-tech names for a 3-6 month momentum trade; upside comes from AI power optionality, but size small because the thesis is hostage to regulatory timing.
• Prefer SMR over NNE for a 6-12 month relative-value expression: SMR has clearer de-risking and should hold up better if the market shifts from story to execution.
• Buy EQIX on dips as a secondary beneficiary of nuclear scarcity, but hedge with a short-duration call spread on power-cost inflation risk; the thesis works if on-site generation becomes a procurement advantage, not a cost overhang.
• For aggressive accounts, consider OKLO Jan-2027 calls funded by selling upside in NNE; this captures the highest convexity to AI-driven nuclear demand while reducing exposure to NNE’s broader execution ambiguity.
• Avoid outright shorting the group into strength; instead wait for a catalyst failure or permitting delay, then pair long SMR / short NNE to isolate regulatory-quality premium over pure hype beta.